Page last updated: 2024-08-25

nsc 361456 and Experimental Neoplasms

nsc 361456 has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dykes, DJ; Griswold, DP; Harrison, SD; Plowman, J; Waud, WR1
Baker, DC; Hand, ES; Haugwitz, RD; Narayanan, VL; Plowman, J; Rampal, JB; Safavy, A1

Other Studies

2 other study(ies) available for nsc 361456 and Experimental Neoplasms

ArticleYear
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6

    Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Pyrazines

1990
Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456).
    Anti-cancer drug design, 1987, Volume: 2, Issue:3

    Topics: Animals; Antineoplastic Agents; Azides; Drug Evaluation, Preclinical; Drug Stability; Female; Half-Life; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Pyrazines; Pyrimethamine; Pyrimidines

1987